esg vs semaglutide
Prescription Weight Loss Rivals Oral Semaglutide? ESG Demands Attention
In a 12-week trial ESG produced a 12.5% total body weight loss, double the 6.1% seen with oral semaglutide. The procedure’s mechanical restriction offers a non-pharmacologic alternative for patients who cannot use GLP-1 injections. Medical Disclaimer: This article is for informational purposes only and does not constitute